KRISTIN HOSTETLER: Open Payments
NPI 1609156470 · FERNANDINA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 28 payments from 10 companies in 2025. Trend: 2023 $1,126 · 2024 $1,430 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| Novo Nordisk Inc | 3 | $43 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: MOUNJARO, Kerendia, GEMTESA, UBRELVY, TRELEGY ELLIPTA, JARDIANCE, SHINGRIX, REXULTI.
Industry payments across FL — which companies pay providers there.
